Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
R&D 100 Award 2014 for ZEISS ELYRA P.1 with 3D-PALM
Thursday, July 24, 2014
ZEISS is receiving Research & Development award once more.

Asylum Research Opens an AFM Demonstration Lab in Mumbai, India
Tuesday, July 22, 2014
New lab to help researchers choose the best AFM for their research.

ZEISS Presents New Correlative Workflows for M&M 2014
Tuesday, July 22, 2014
FIB-SEM, X-ray and correlative workflows showcased at M&M 2014.

VolitionRx Sells First NuQ® Research Use Only Kits to Active Motif
Tuesday, June 24, 2014
First revenues from VolitionRx Nucleosomics technology.

New Webinar on Improving Process Development Timelines with Mini Bioreactors
Saturday, June 21, 2014
Details fermentation and bioprocessing data generated by ambr250.

Lonza Innovation Showcase Features Novel Culture System at ISSCR
Saturday, June 21, 2014
Company has introduced L7™ hiPSC reprogramming and hPSC culture system at ISSCR.

Updates to Eppendorf Website Combine Online Purchasing with a Wealth of Information
Friday, June 20, 2014
New, updated version of Eppendorf’s UK website.

lnSphero Launches Cytotoxicity Assay Kit for 3D Cell Culture
Wednesday, June 18, 2014
The Assay Kit incorporates Promega technology to measure cell viability in 3D microtissues, offering complete solution for toxicity and efficacy testing.

lnSphero Launches 3D InSight™ Pancreatic Microislets for Diabetes, Toxicity Research
Wednesday, June 18, 2014
Recently published 3D human and rat "pseudo­ islets" display long-lived, robust metabolic activity, offer convenient solution for islet transplantation, anti-diabetic drug development, and assessment of acute and chronic toxicity of the endocrine pancreas.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 221
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv